resveratrolFinding
Resveratrol has no detected effect on serum alkaline phosphatase
no difference foundStrong evidenceFinding
01 · The sentence it was drawn from
“As shown in Fig. 4 and Table 3, there were no significant differences between placebo and resveratrol group in the serum biomarkers including ALP (MD: 2.53, 95% CI: − 2.47, 7.52, p = 0.32, 9 studies, 523 participants), BAP (MD: 1.93, 95% CI: − 2.60, 6.47, p = 0.40, 2 studies, 90 participants), CTX (MD: -0.01, 95% CI: − 0.06, 0.03, p = 0.59, 3 studies, 218 participants), OCN (MD: -1.27, 95% CI: − 2.99, 0.46, p = 0.15, 3 studies, 218 participants), PINP (MD: -2.92, 95% CI: − 6.33, 0.50, p = 0.09, 2 studies, 90 participants), and PTH (MD: -0.86, 95% CI: − 1.75, 0.03, p = 0.06, 2 studies, 90 participants).”
resveratrol
Serum alkaline phosphatase
no difference found
Effect as reported
2.53mean difference
CI −2.47 to 7.52
- Who
- n = 523 · adults in 9 pooled RCTs (type 2 diabetes, NAFLD, obesity, healthy elderly and postmenopausal women), resveratrol 8 mg to 1500 mg daily against placebo, 4 weeks to 12 months; some trials with background medication in both arms
- Dose studied
- pooled doses 8 mg to 1500 mg daily, oral capsules or tablets
Strong evidencePMID 34420523 · 2021
02 · The study
- Study
- meta-analysis
- Participants
- 523
- Duration
- not reported
Evidence, by strength
- strongthis finding
- moderate
- limited
- very limited
- insufficient
03 · The paper
BMC complementary medicine and therapies04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M6ZB47GY6BRP285AQ0FA2S3Q